{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:07:43Z","timestamp":1780934863514,"version":"3.54.1"},"reference-count":64,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Midwife Womens Health"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>HIV infection is a major public health problem for women in the United States. Prevention of new HIV infections is essential to the goal of eliminating HIV in the United States. Pre\u2010exposure prophylaxis (PrEP) is an effective and safe HIV prevention method recommended for women at increased risk for HIV infection, including during pregnancy and lactation. The recommended PrEP regimen is a fixed\u2010dose combination of tenofovir disoproxil fumarate and emtricitabine administered as a single daily dose. The initial evaluation for individuals desiring PrEP for HIV prevention includes obtaining a history, laboratory evaluation, and evaluation of the accessibility and acceptability of PrEP. Individuals using PrEP medications are seen every 3 months for follow\u2010up. These follow\u2010up visits include evaluation for signs and symptoms of seroconversion, management of side effects and adverse reactions, and evaluation of adherence to PrEP. Follow\u2010up visits also include testing for HIV, sexually transmitted infections, and renal function and a review of HIV prevention and risk reduction methods. Despite known safety and efficacy of PrEP among women, PrEP use in women in the United States remains low. Gaps exist in HIV prevention that can in part be addressed by women's health care providers through risk screening and provision of HIV prevention methods. All providers of comprehensive sexual health care can and should assess individuals for risk factors for HIV infection and offer HIV prevention methods, including PrEP, to individuals at risk for HIV.<\/jats:p>","DOI":"10.1111\/jmwh.13231","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T15:28:37Z","timestamp":1622820517000},"page":"322-333","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pre\u2010Exposure Prophylaxis for HIV Infection and the Role of the Women's Health Care Provider in HIV Prevention"],"prefix":"10.1111","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0424-2678","authenticated-orcid":false,"given":"Leah B.","family":"Ruppe","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences University of Maryland School of Medicine  Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Spencer","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences University of Maryland School of Medicine  Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Kriebs","sequence":"additional","affiliation":[{"name":"Midwifery Institute at Jefferson University  Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"Diagnoses of HIV Infection in the United States and Dependent Areas 2018: Women.Centers for Disease Control and Prevention.2020. Accessed August 17 2020.https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv\u2010surveillance\/vol\u201031\/content\/women.html"},{"key":"e_1_2_12_3_1","unstructured":"Diagnoses of HIV infection in the United States and dependent areas 2018:diagnoses. Centers for Disease Control and Prevention.2020. Accessed August 17 2020.https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv\u2010surveillance\/vol\u201031\/content\/diagnoses.html#gender"},{"key":"e_1_2_12_4_1","unstructured":"Centers for Disease Control and Prevention.Estimated HIV Incidence and Prevalence in the United States 2014\u20132018. HIV Surveillance Supplemental Report2020;25(1). Accessed January 24 2021.https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc\u2010hiv\u2010surveillance\u2010supplemental\u2010report\u2010vol\u201025\u20101.pdf"},{"key":"e_1_2_12_5_1","unstructured":"About HIV.Centers for Disease Control and Prevention. Accessed January 24 2021.https:\/\/www.cdc.gov\/hiv\/basics\/whatishiv.html"},{"issue":"49","key":"e_1_2_12_6_1","first-page":"665","article-title":"Recommendations for assisting in the prevention of perinatal transmission of human T\u2010lymphotropic virus type III\/lymphadenopathy\u2010associated virus and acquired immunodeficiency syndrome","volume":"31","author":"Centers for Disease Control and Prevention","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"52","key":"e_1_2_12_7_1","first-page":"697","article-title":"Immunodeficiency among female sexual partners of males with acquired immune deficiency syndrome (AIDS) \u2010 New York","volume":"31","author":"Centers for Disease Control and Prevention","year":"1983","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"04","key":"e_1_2_12_8_1","first-page":"64","article-title":"AIDS: the early years and CDC's response","volume":"60","author":"Curran JW","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"48","key":"e_1_2_12_9_1","first-page":"721","article-title":"Current trends recommendations for assisting in the prevention of perinatal transmission of human T\u2010lymphotropic virus type iii\/lymphadenopathy\u2010associated virus and acquired immunodeficiency syndrome","volume":"34","author":"Centers for Disease Control and Prevention","year":"1985","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001455"},{"key":"e_1_2_12_11_1","volume-title":"Position Statement: Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS)","author":"American College of Nurse\u2010Midwives","year":"2017"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)06231-9"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69157-5"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6903a2"},{"key":"e_1_2_12_15_1","unstructured":"Department of Health and Human Services: Panel on Antiretroviral Guidelines for Adults and Adolescents.Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services.2021. Accessed January 28 2021.https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/AdultandAdolescentGL.pdf"},{"key":"e_1_2_12_16_1","unstructured":"Centers for Disease Control and Prevention US Public Health Service:Preexposure Prophylaxis for the Prevention of HIV Infection in the United States\u20142017 Update: A Clinical Practice Guideline. Centers for disease Control and Prevention; 2017. Accessed October 2020.https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc\u2010hiv\u2010prep\u2010guidelines\u20102017.pdf.Published"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17025"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30458-1"},{"key":"e_1_2_12_19_1","unstructured":"HIV in the United States by region.Centers for Disease Control and Prevention. Accessed August 17 2020.https:\/\/www.cdc.gov\/hiv\/statistics\/overview\/geographicdistribution.html"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0194"},{"key":"e_1_2_12_21_1","unstructured":"Department of Health and Human Services: Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission.Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States. Department of Health and Human Services;2020. Accessed January 30 2021.https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/Perinatal_GL_2020.pdf"},{"key":"e_1_2_12_22_1","unstructured":"Centers for Disease Control and Prevention.Vaginal sex and HIV risk.2019. Ways HIV can be transmitted. Accessed September 16 2020.https:\/\/www.cdc.gov\/hiv\/risk\/vaginalsex.html"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.2.21295"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000446855.78026.21"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61127-7"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602046"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023055"},{"key":"e_1_2_12_28_1","unstructured":"World Health Organization.WHO Implementation Tool for Pre\u2010Exposure Prophylaxis (PrEP) of HIV Infection. Module 1: Clinical. World Health Organization; 2017. Accessed August 20 2020.https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255889\/WHO\u2010HIV\u20102017.17\u2010eng.pdf?sequence=1"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200204150-00009"},{"issue":"2","key":"e_1_2_12_30_1","first-page":"1","article-title":"Antiretroviral postexposure prophylaxis after sexual, injection\u2010drug use, or other nonoccupational exposure to HIV in the United States recommendations from the US Department of Health and Human Services","volume":"54","author":"Smith DK","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"e_1_2_12_31_1","first-page":"1","article-title":"Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis","volume":"50","author":"US Public Health Service","year":"2001","journal-title":"MMWR Recomm Rep"},{"issue":"31","key":"e_1_2_12_32_1","first-page":"586","article-title":"Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402269"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01143-8"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506110"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1193748"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.2591"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110711"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202614"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50052"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.06.020"},{"key":"e_1_2_12_43_1","unstructured":"Antiretroviral Pregnancy Registry Steering Committee.Antiretroviral Pregnancy Registry Interim Report: 1 January 1989 through 31 January 2020. Antiretroviral Pregnancy Registry Steering Committee; 2019. Accessed September 13 2020.http:\/\/www.apregistry.com\/forms\/interim_report.pdf."},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu798"},{"key":"e_1_2_12_45_1","unstructured":"Food and Drug Administration.Truvada prescribing information. 2013. Accessed January 31 2021.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021752s035lbl.pdf"},{"issue":"03","key":"e_1_2_12_46_1","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski KA","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_12_47_1","unstructured":"HCV testing and linkage to care. AmericanAssociation for the Study of Liver Diseases.2020. Accessed February 7 2021.https:\/\/www.hcvguidelines.org\/evaluate\/testing\u2010and\u2010linkage"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2020.0231"},{"issue":"1","key":"e_1_2_12_49_1","first-page":"26","article-title":"Women are less likely to be tested for hiv or offered preexposure prophylaxis at the time of sexually transmitted infection diagnosis","volume":"48","author":"Yumori C","year":"2020","journal-title":"Sex Transm Dis"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000730"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2018.7353"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01295-0"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2016.1153595"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1625-1"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2017.0201"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2014.0142"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-2182(93)90141-3"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-2182(98)00055-X"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2012.05.005"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/jmwh.12987"},{"key":"e_1_2_12_61_1","unstructured":"HIV Nexus: CDC resources for clinicians.Centers for Disease Control and Prevention.2020. Accessed February 9 2021.https:\/\/www.cdc.gov\/hiv\/clinicians\/index.html"},{"key":"e_1_2_12_62_1","unstructured":"HIV consultation and referral services.Centers for Disease Control and Prevention. 2021. Accessed February 9 2021.https:\/\/www.cdc.gov\/hiv\/library\/hotlines.html"},{"key":"e_1_2_12_63_1","unstructured":"HIVE: A hub of positive reproductive and sexual health.University of California San Francisco. 2014. Accessed February 9 2021.https:\/\/hiveonline.org\/"},{"key":"e_1_2_12_64_1","unstructured":"Understanding HIV.National Institutes of Health. Accessed February 9 2021.https:\/\/hivinfo.nih.gov\/understanding\u2010hiv"},{"key":"e_1_2_12_65_1","unstructured":"HIV\/AIDS.World Health Organization.2021. Accessed February 9 2021.https:\/\/www.who.int\/hiv\/pub\/prep\/prep\u2010implementation\u2010tool\/en\/"}],"container-title":["Journal of Midwifery &amp; Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jmwh.13231","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jmwh.13231","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jmwh.13231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T17:19:46Z","timestamp":1693156786000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jmwh.13231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1111\/jmwh.13231"],"URL":"https:\/\/doi.org\/10.1111\/jmwh.13231","archive":["Portico"],"relation":{},"ISSN":["1526-9523","1542-2011"],"issn-type":[{"value":"1526-9523","type":"print"},{"value":"1542-2011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"2020-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}